OmniAb Enters In Technology License And Services Agreement For Antibody Discovery With A Newly-Formed Incubated Company Of Arrowmark Partners And Viking Global Investors
Nov 17 (Reuters) - OmniAb Inc OABI.O:
OMNIAB ENTERS INTO A TECHNOLOGY LICENSE AND SERVICES AGREEMENT FOR ANTIBODY DISCOVERY WITH A NEWLY-FORMED INCUBATED COMPANY OF ARROWMARK PARTNERS AND VIKING GLOBAL INVESTORS
OMNIAB INC - TO RECEIVE REVENUE FOR SERVICES, EQUITY, AND ROYALTIES UNDER AGREEMENT
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.